|
IQVIA™ Real-World Insights Bibliography
| Empagliflozin is Associated with Lower Risk of Cardiovascular Events and All-Cause Mortality in Routine Care in East Asia: Results from the EMPRISE Study
|
| Author(s): Dae Jung Kim (1), Wayne H-H Sheu (2), Wook-Jin Chung (3), Daisuke Yabe (4-7), Kyoung Hwa Ha (1), Masaomi Nangaku (8), Elise Chia-Hui Tan (9), Koichi Node (10), Atsutaka Yasui (11), Weiyu Lei (12), Sunwoo Lee (13), Laura Saarelainen (14), Anouk Deruaz-Luyet (15), Moe H. Kyaw (16) and Yutaka Seino (4,17), EMPRISE East Asia Study Group
|
| Affiliations(s): "1
Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, South Korea
2
Division of Endocrinology and Metabolism, Taipei Veterans General Hospital, Taipei, Taiwan
3
Department of Cardiovascular Medicine, Gachon University Gil Medical Center, Incheon, South Korea
4
Kansai Electric Power Medical Research Institute, Kobe, Japan
5
Department of Diabetes, Metabolism and Endocrinology/Department of Rheumatology and Clinical Immunology, Gifu University Graduate School of Medicine, Gifu, Japan
6
Center for Healthcare Information Technology, Tokai National Higher Education and Research System, Nagoya, Japan
7
Division of Metabolism and Molecular Medicine, Kobe University Graduate School of Medicine, Kobe, Japan
8
Division of Nephrology and Endocrinology, The University of Tokyo, Tokyo, Japan
9
National Research Institute of Chinese Medicine, Ministry of Health and Welfare, Taipei, Taiwan, and Institute of Hospital and Healthcare Administration, National Yang-Ming University, Taipei, Taiwan
10
Department of Cardiovascular Medicine, Saga University, Saga, Japan
11
Nippon Boehringer Ingelheim Co. Ltd., Tokyo, Japan
12
Boehringer Ingelheim Taiwan Ltd., Taipei, Taiwan
13
Boehringer Ingelheim Korea Ltd, Seoul, Korea
14
IQVIA, Espoo, Finland
15
Boehringer Ingelheim International GmbH, Ingelheim, Germany
16
Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA
17
Kansai Electric Power Hospital, Osaka, Japan
" |
Publication(s): "JDI journal
Virtual Conference: ACC, May 2021"
|
| Document Type(s): Article, |
| Countries: Japan, Korea, Taiwan, |
| Click here for the abstract |
C:
Y: |
Cardiovascular disease, Diabetes, Drug safety, Drug Utlization Study,
2023 |
|
L:
A: |
English
Clinical setting: hospital, Clinical setting: Primary care, Retrospective cohort analysis, |
|
 |
| |
| |
| Health-related quality of life in patients with alopecia areata: Results of a Japanese survey with norm-based comparisons |
| Author(s): Taisuke Ito 1, Kazumasa Kamei 2, Akira Yuasa 3, Fumihiro Matsumoto 2, Yayoi Hoshi 4, Masafumi Okada 4, Shinichi Noto 5 (rwesheorj 4) |
| Affiliations(s): 1) Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, Japan
2) Inflammation and Immunology Medical Affairs, Pfizer Japan Inc., Tokyo, Japan
3) Health and Value, Pfizer Japan Inc., Tokyo, Japan
4) Real-World Evidence Solutions & HEOR, IQVIA Solutions Japan K.K., Tokyo, Japan |
Publication(s): The Journal of Dermatology
|
| Document Type(s): Online article, |
| Countries: Japan, |
| Click here for the abstract |
C:
Y: |
Dermatology, Mental health,
2022 |
|
L:
A: |
English
Patient questionnaire, Quality of life, Survey research, |
|
|
| |
| |
| Physician awareness and understanding of hereditary angioedema: A web-based study in Japan |
| Author(s): Atsushi Fukunaga MD, PhD1,2| Miwa Kishimoto MD, PhD3| Akinori Oh PhD3|Takeshi Akiyama MBA4| Ippei Kotera PhD3| Yoichi Inoue MD, JD3| Junichi Maehara MD5 |
| Affiliations(s): 1Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Hyogo, Japan2Division of Medicine for Function and Morphology of Sensory Organs, Department of Dermatology, Faculty of Medicine, Osaka Medical and Pharmaceutical University, Takatsuki, Japan3Japan Medical Office, Takeda Pharmaceutical Company Limited, Tokyo, Japan4Real World Evidence Solutions & HEOR, IQVIA Solutions Japan K.K., Tokyo, Japan5Department of Acute Care and General Medicine, Emergency and Critical Care Center, Saiseikai Kumamoto Hospital, Kumamoto, Japan |
Publication(s): Journal of Cutaneous Immunology and Allergy.
|
| Document Type(s): Article, |
| Countries: Japan, |
| Click here for the abstract |
C:
Y: |
Rare disease,
2022 |
|
L:
A: |
English
Survey research, |
|
|
| |
| |
| Cost-Effectiveness of Vonoprazan Compared With Proton Pump Inhibitors in Patients Taking Low-Dose Aspirin for Secondary Prevention of Cardiovascular Events in Japan |
| Author(s): Masanobu Ishii, Takashi Kawai, Kenichi Tsujita, Ataru Igarashi, Manabu Suzuki, Hisato Deguchi, Jovelle Fernandez |
| Affiliations(s): Masanobu Ishii
Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University [Japan]
Takashi Kawai
Department of Gastroenterological Endoscopy, Tokyo Medical University [Japan]
Kenichi Tsujita
Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University [Japan]
Ataru Igarashi
Department of Health Economics and Outcomes Research, Graduate School of Pharmaceutical Sciences, The University of Tokyo [Japan]
Manabu Suzuki
Japan Medical Office, Takeda Pharmaceutical Company Limited [Japan]
Hisato Deguchi
Japan Medical Office, Takeda Pharmaceutical Company Limited [Japan]
Jovelle Fernandez
Japan Medical Office, Takeda Pharmaceutical Company Limited [Japan] |
Publication(s): Circulation Journal
|
| Document Type(s): Article, |
| Countries: Japan, |
| Click here for the abstract |
C:
Y: |
Cardiovascular disease,
2022 |
|
L:
A: |
English
Cost effectiveness, |
|
|
| |
| |
| Development of a clinical prediction model for recurrence and mortality outcomes after Clostridioides difficile infection using a machine learning approach |
| Author(s): Daniel Ruzicka 1, Takayuki Kondo 1, Go Fujimoto 1, Andrew P.Craig 2, Seok-Won Kim 2, Hiroshige Mikamo 3 |
| Affiliations(s): 1) Medical Affairs, MSD K.K., Tokyo, Japan, Kitanomaru Square, 1-13-12 Kudan-kita, Chiyoda-ku, Tokyo, 102-8667, Japan
2) Real World Evidence Solutions, IQVIA Solutions Japan K.K., Takanawa 4-10-18, Minato-ku, Tokyo, 108-0074, Japan
3) Department of Clinical Infectious Diseases, Aichi Medical University Graduate School of Medicine, 1-1, Yazakokarimata, Nagakute, Aichi, 480-1195, Japan |
Publication(s): Anaerobe
|
| Document Type(s): Article, |
| Countries: Japan, |
| Click here for the abstract |
C:
Y: |
Infectious disease,
2022 |
|
L:
A: |
English
Methodology, |
|
|
| |
| |
| Assessing the correlation between second progression-free survival (PFS2) and overall survival (OS) in advanced prostate cancer patients using medical data vision (MDV) claims database in Japan |
| Author(s): Masaki Shiota 1,Raf De Moor 2,Yosuke Koroki 2,Dae Young Yu 3,David Bin-Chia Wu 4 |
| Affiliations(s): 1) Department of Urology, Graduate School of Medical Sciences, Kyushu University Hospital, Fukuoka, Japan
2) Integrated Market Access, Janssen Pharmaceutical KK, Tokyo, Japan
3) Janssen Pharmaceutical Companies of Johnson and Johnson, Asia Pacific Regional Office, Singapore, Singapore
4) Janssen Pharmaceutical Companies of Johnson and Johnson, Asia Pacific Regional Office, Singapore, Singapore;e Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore;f School of Pharmacy, Monash University Malaysia, Bandar Sunway, Malaysia |
Publication(s): Current Medical Research and Opinion
|
| Document Type(s): Article, |
| Countries: Japan, |
| Click here for the abstract |
C:
Y: |
Oncology,
2022 |
|
L:
A: |
English
Database Study, |
|
|
| |
| |
| Budget impact analysis of Jivi® (damoctocog alfa pegol, BAY 94-9027) in severe Hemophilia A in Japan |
| Author(s): Teruhisa Fujii 1, Yuko Kidoguchi 2, Noriko Takahashi 2, Eric Yu 3, Dilinuer Ainiwaer 3, Aidan Byrne 4 (rwesheorj 3) |
| Affiliations(s): 1) Division of Blood Transfusion, Hiroshima University Hospital, Hiroshima, Japan
2) Market Access, Bayer Yakuhin, Ltd., Tokyo, Japan
3) IQVIA Solutions Japan K.K., Tokyo, Japan
4) IQVIA UK, London, UK |
Publication(s): Journal of Medical Economics
|
| Document Type(s): Article, |
| Countries: Japan, |
| Click here for the abstract |
C:
Y: |
Health economics,
2021 |
|
L:
A: |
English
Budget impact, |
|
|
| |
| |
| Real-world treatment and health care resource use among severe asthma patients in Japan |
| Author(s): Yasuo To 1, Yurie Taguchi 2, Tatsuya Shimazaki 2, Kazuhiko Arima 2, Eric Yu 3, Sven Demiya 3, Takashi Iwanaga 4 (rwesheorj 3) |
| Affiliations(s): 1) Department of Pulmonary Medicine, International University of Health and Welfare, School of Medicine, 1-4-3 Mita, Minato-ku, Tokyo 108-8329, Japan
2) Sanofi K.K., 3-20-2 Nishi Shinjuku, Shinjuku-ku, Tokyo 163-1488, Japan
3) IQVIA Solutions Japan K.K., Keikyu Dai-7 Building 4-10-8, Takanawa Minato-ku, Tokyo 108-0074, Japan
4) Kindai University, 377-2 Ohno Higashi, Osakasayama City, Osaka 589-8511, Japan |
Publication(s): Respiratory Investigation
|
| Document Type(s): Article, |
| Countries: Japan, |
| Click here for the abstract |
C:
Y: |
Clinical practice,
2021 |
|
L:
A: |
English
Database Study, |
|
|
| |
| |
| Cost-effectiveness analysis of the treatment strategies with or without opioid medications in surgery-eligible patients with osteoarthritis in Japan |
| Author(s): Tomoyuki Takura 1, Akira Yuasa 2, Naohiro Yonemoto 2, Sven Demiya 3, Hiroyuki Matsuda 3, Nozomi Ebata 4, Koichi Fujii 4, Muneaki Ishijima 5 (rwesheorj 3) |
| Affiliations(s): 1) Department of Healthcare Economics and Health Policy, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
2) Health and Value, Pfizer Japan Inc., Shinjuku Bunka Quint Building, 3-22-7, Yoyogi, Shibuya-ku, Tokyo, 151-8589, Japan
3) IQVIA Solutions Japan K.K., Tokyo, Japan
4) Medical Affairs, Pfizer Japan Inc, Tokyo, Japan
5) Department of Medicine for Orthopaedics and Motor Organ, Juntendo University Graduate School of Medicine, Tokyo, Japan |
Publication(s): PharmacoEconomics - Open
|
| Document Type(s): Article, |
| Countries: Japan, |
| Click here for the abstract |
C:
Y: |
Health economics,
2021 |
|
L:
A: |
English
Cost effectiveness, Literature Review, |
|
|
| |
| |
| Healthcare resource utilization and economic burden of antifungal management in patients with hematologic malignancy in Japan: a retrospective database study |
| Author(s): Rie Ueno 1, Shinichi Nishimura 1, Go Fujimoto 1, Dilinuer Ainiwaer 2 (rwesheorj 2) |
| Affiliations(s): 1) MSD K.K, Tokyo, Japan
2) IQVIA Solutions Japan K.K., Tokyo, Japan |
Publication(s): Current Medical Research and Opinion
|
| Document Type(s): Article, |
| Countries: Japan, |
| Click here for the abstract |
C:
Y: |
Infectious disease,
2021 |
|
L:
A: |
English
Database Study, |
|
|
| |
| |
 1 of 6 
|
|
